Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
基本信息
- 批准号:8432053
- 负责人:
- 金额:$ 35.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-06 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesB cell differentiationB-Cell DevelopmentB-LymphocytesBloodBlood CellsBone MarrowCell LineCell ProliferationCell modelCommitDataDefectDevelopmentDiseaseDoseDown-RegulationEventGene ExpressionGene Expression ProfilingGene TargetingGenerationsGenesGoalsHealthHematological DiseaseHematopoieticHematopoietic stem cellsHomeostasisHoxA proteinImmune systemImmunodeficiency and CancerImmunologic Deficiency SyndromesInfectionInterventionKnowledgeLearningLeukocytesLifeLigandsLinkLymphoidLymphopoiesisMediatingMicroarray AnalysisMolecularMolecular TargetMusPathway interactionsPatternPlayProcessProductionProteinsRag1 MouseReceptor Protein-Tyrosine KinasesRegulationRegulator GenesReporterResearch DesignRoleSeriesSignal TransductionStem Cell DevelopmentStem cellsTCF3 geneTestingTranscriptanimal databasecytokinedesignfightingfunctional genomicshelix-loop-helix protein differentiation inhibitorhumoral immunity deficiencyinsightinterestleukemianoveloverexpressionprogenitorprotein Bresearch studystem cell biologytranscription factor
项目摘要
DESCRIPTION (provided by applicant): B lymphocytes are critical blood cells and altered production or function can cause significant disease. We are interested in understanding how blood stem cells initiate B cell development. Delineating the normal B cell developmental pathway will provide insight into the molecular and cellular basis of many hematologic diseases. Although considerable progress has been made in understanding the generation of naive B cells from committed B cell precursors, little is known about how this process begins. This project will exploit exciting new findings concerning an unexpected regulatory connection between the receptor tyrosine kinase Flt3, HoxA proteins, and the B cell fate determinant EBF. Our new data suggest that this regulatory connection plays an important role in regulating the stem cell to Pro-B transition, and hence, the numbers of B lymphocytes generated. Specifically, we will learn how Flt3 signaling initiates a series of events, gradually biasing multipotential progenitors in bone marrow into the B lineage. Exciting new data revealed that Flt3 signaling, in a ligand-dose dependent fashion, regulates the activity of the primary B cell fate determinant, E2A, a key regulator of the EBF gene. Once expressed, EBF orchestrates B cell differentiation. Gene expression profiling of an EBF-/- cell line pointed to novel role for EBF during B cell development, namely controlling expression of a developmentally regulated cluster of HoxA proteins. Elucidating regulatory circuits that control HoxA expression is important, as dysregulated expression impairs B cell differentiation. First we will determine the molecular events between Flt3 signaling and EBF expression. Then we will determine the regulatory connection between EBF, HoxA, and Flt3 that controls the production of B lymphocytes. Overall, these experiments will provide basic knowledge of a vital process, the production of white blood cells that make antibodies to fight infections. The information should help identify molecular targets for intervention in blood cell cancers and immunodeficiency diseases.
描述(由申请人提供):B淋巴细胞是关键的血细胞,产生或功能的改变会导致重大疾病。我们有兴趣了解血液干细胞如何启动B细胞的发育。描述正常B细胞发育途径将为许多血液学疾病的分子和细胞基础提供洞察力。尽管在理解固定的B细胞前体的幼稚B细胞的产生方面取得了很大进展,但对该过程的开始知之甚少。该项目将利用有关受体酪氨酸激酶FLT3,HOXA蛋白和B细胞命运决定因素EBF之间意外调节连接的令人兴奋的新发现。我们的新数据表明,这种调节性连接在调节干细胞对pro-b转变以及产生的B淋巴细胞数量中起着重要作用。具体而言,我们将学习FLT3信号如何启动一系列事件,逐渐使骨髓中的多次祖细胞偏向B谱系。令人兴奋的新数据表明,FLT3信号以配体依赖性方式调节了EBF基因的关键调节剂E2A的主要B细胞命运决定簇的活性。一旦表达,EBF就会策划B细胞分化。 EBF - / - 细胞系的基因表达分析指向B细胞发育过程中EBF的新作用,即控制发育调节的HOXA蛋白簇的表达。阐明控制HOXA表达的调节回路很重要,因为失调的表达会损害B细胞分化。首先,我们将确定FLT3信号传导和EBF表达之间的分子事件。然后,我们将确定控制B淋巴细胞产生的EBF,HOXA和FLT3之间的调节连接。总体而言,这些实验将提供有关至关重要过程的基本知识,即产生抗体感染的抗体的白细胞的产生。该信息应有助于确定用于干预血细胞癌和免疫缺陷疾病的分子靶标。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hoxa9 regulates Flt3 in lymphohematopoietic progenitors.
- DOI:10.4049/jimmunol.0904203
- 发表时间:2010-12-01
- 期刊:
- 影响因子:0
- 作者:Gwin K;Frank E;Bossou A;Medina KL
- 通讯作者:Medina KL
Cell extrinsic alterations in splenic B cell maturation in Flt3-ligand knockout mice.
- DOI:10.1002/iid3.54
- 发表时间:2015-06
- 期刊:
- 影响因子:3.2
- 作者:Dolence, Joseph J;Gwin, Kimberly A;Shapiro, Mariya B;Hsu, Fan-Chi;Shapiro, Virginia S;Medina, Kay L
- 通讯作者:Medina, Kay L
Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
- DOI:10.1186/s12865-016-0152-1
- 发表时间:2016-06-10
- 期刊:
- 影响因子:3
- 作者:Xu Z;Gwin KA;Li Y;Medina KL
- 通讯作者:Medina KL
Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors.
来自 Flt3 多能祖细胞的 B、NK 和 DC 谱系细胞的发育和分化对 Hoxa9 的差异要求。
- DOI:10.1186/1471-2172-14-5
- 发表时间:2013
- 期刊:
- 影响因子:3
- 作者:Gwin,Kimberly;Dolence,JosephJ;Shapiro,MariyaB;Medina,KayL
- 通讯作者:Medina,KayL
Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1.
- DOI:10.1371/journal.pone.0078408
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Medina KL;Tangen SN;Seaburg LM;Thapa P;Gwin KA;Shapiro VS
- 通讯作者:Shapiro VS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kay Lynn Medina其他文献
Kay Lynn Medina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kay Lynn Medina', 18)}}的其他基金
Cell-extrinsic emergency myelopoiesis regulated by ABCB7
ABCB7 调控的细胞外紧急骨髓细胞生成
- 批准号:
10675321 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Regulation of the lymphoid cell fate by Hoxa9
Hoxa9 对淋巴细胞命运的调节
- 批准号:
10546476 - 财政年份:2022
- 资助金额:
$ 35.96万 - 项目类别:
Regulation of the lymphoid cell fate by Hoxa9
Hoxa9 对淋巴细胞命运的调节
- 批准号:
10390559 - 财政年份:2022
- 资助金额:
$ 35.96万 - 项目类别:
Maintenance and targeting of bone marrow derived allo-reactive human plasma cells
骨髓来源的同种异体反应性人浆细胞的维持和靶向
- 批准号:
9164092 - 财政年份:2016
- 资助金额:
$ 35.96万 - 项目类别:
Maintenance and targeting of bone marrow derived allo-reactive human plasma cells
骨髓来源的同种异体反应性人浆细胞的维持和靶向
- 批准号:
9307716 - 财政年份:2016
- 资助金额:
$ 35.96万 - 项目类别:
Regulation of erythroid maturation by the transcriptional repressor NKAP
转录抑制因子 NKAP 对红细胞成熟的调节
- 批准号:
8911512 - 财政年份:2015
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
7799155 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
8040992 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
8232043 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
Molecular Events Initiating B Cell Fate Determination
启动 B 细胞命运决定的分子事件
- 批准号:
7650758 - 财政年份:2009
- 资助金额:
$ 35.96万 - 项目类别:
相似国自然基金
缺氧通过HIF1α/TXNDC5通路调控IgG4相关性疾病B细胞分化及抗体类别转换重组
- 批准号:82302028
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
大疱性类天疱疮血浆外泌体通过miR-148a-3p/DNMT1/Blimp-1轴调控B细胞异常分化的作用及分子机制
- 批准号:81903208
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
转录因子EBF1在间充质干细胞调控B细胞分化治疗抗体介导排斥反应中的作用及机制
- 批准号:81870511
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
甲戊二羟酸代谢途径调控B淋巴细胞活化、亚群分化、抗体应答的分子机制及相关疾病的研究
- 批准号:81730043
- 批准年份:2017
- 资助金额:293.0 万元
- 项目类别:重点项目
Tfr细胞调控Tfh细胞介导的B细胞分化在狼疮肾炎发病中的作用机制研究
- 批准号:81701595
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Tissue-engineered Aged B Cell Immune Organoid to Study Antibody Secreting Cell Differentiation Trajectory
组织工程老化 B 细胞免疫类器官用于研究抗体分泌细胞分化轨迹
- 批准号:
10804886 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Project 3: Defining adaptive immune interactions that shape Clostridioides difficile infection
项目 3:定义影响艰难梭菌感染的适应性免疫相互作用
- 批准号:
10625579 - 财政年份:2023
- 资助金额:
$ 35.96万 - 项目类别:
Enhancing CAR T therapy in multiple myeloma
增强多发性骨髓瘤的 CAR T 疗法
- 批准号:
10588210 - 财政年份:2022
- 资助金额:
$ 35.96万 - 项目类别: